February, 2010
No. 95 (2)

Editorials

Molecular basis of juvenile myelomonocytic leukemia

Andrica C.H. de Vries, C. Michael Zwaan, Marry M. van den Heuvel-Eibrink

https://doi.org/10.3324/haematol.2009.016865

Review Articles

Lymphoma stem cells: enough evidence to support their existence?

Jose A. Martinez-Climent, Lorena Fontan, Randy D. Gascoyne, Reiner Siebert, Felipe Prosper

https://doi.org/10.3324/haematol.2009.013318

Articles

Cryohydrocytosis: increased activity of cation carriers in red cells from a patient with a band 3 mutation

Anna Bogdanova, Jeroen S. Goede, Erwin Weiss, Nikolay Bogdanov, Poul Bennekou, Ingolf Bernhardt, Hans U. Lutz

https://doi.org/10.3324/haematol.2009.010215

Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-α treatment

Gaetano Bergamaschi, Antonio Di Sabatino, Riccardo Albertini, Sandro Ardizzone, Paolo Biancheri, Elisa Bonetti, Andrea Cassinotti, Paolo Cazzola, Konstantinos Markopoulos, Alessandro Massari, Vittorio Rosti, Gabriele Bianchi Porro, Gino R. Corazza

https://doi.org/10.3324/haematol.2009.009985

Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations

Paola Quarello, Emanuela Garelli, Adriana Carando, Alfredo Brusco, Roberto Calabrese, Carlo Dufour, Daniela Longoni, Aldo Misuraca, Luciana Vinti, Anna Aspesi, Laura Biondini, Fabrizio Loreni, Irma Dianzani, Ugo Ramenghi

https://doi.org/10.3324/haematol.2009.011783

Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells

Valeria Visconte, Nalini Raghavachari, Delong Liu, Keyvan Keyvanfar, Marie J. Desierto, Jichun Chen, Neal S. Young

https://doi.org/10.3324/haematol.2009.011650

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Dragana Milojkovic, Emma Nicholson, Jane F. Apperley, Tessa L. Holyoake, Pat Shepherd, Mark W. Drummond, Richard Szydlo, Marco Bua, Letizia Foroni, Alistair Reid, Jamshid S. Khorashad, Hugues de Lavallade, Katy Rezvani, Christos Paliompeis, John M. Goldman, David Marin

https://doi.org/10.3324/haematol.2009.012781

Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase chronic myeloid leukemia patients with resistance, suboptimal response or intolerance to imatinib

Neil P. Shah, Dong-Wook Kim, Hagop Kantarjian, Philippe Rousselot, Pedro Enrique Dorlhiac Llacer, Alicia Enrico, Jorge Vela-Ojeda, Richard T. Silver, Hanna Jean Khoury, Martin C. Müller, Alexandre Lambert, Yousif Matloub, Andreas Hochhaus

https://doi.org/10.3324/haematol.2009.011452

Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia

Thomas Burmeister, Nicola Gökbuget, Stefan Schwartz, Lars Fischer, Daniela Hubert, Annette Sindram, Dieter Hoelzer, Eckhard Thiel

https://doi.org/10.3324/haematol.2009.011346

Double-staining chromogenic in situ hybridization as a useful alternative to split-signal fluorescence in situ hybridization in lymphoma diagnostics

Anke van Rijk, Tim Svenstroup-Poulsen, Margaret Jones, José Cabeçadas, Juan Cruz Cigudosa, Lorenzo Leoncini, Anja Mottok, Christiane Copie Bergman, Evi Pouliou, Stephen Hamilton Dutoit, Han J. van Krieken

https://doi.org/10.3324/haematol.2009.011635

Pediatric follicular lymphoma – a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin’s Lymphoma - Berlin-Frankfurt-Münster (NHL-BFM) multicenter trials

Ilske Oschlies, Itziar Salaverria, Friederike Mahn, Andrea Meinhardt, Martin Zimmermann, Wilhelm Woessmann, Birgit Burkhardt, Stefan Gesk, Matthias Krams, Alfred Reiter, Reiner Siebert, Wolfram Klapper

https://doi.org/10.3324/haematol.2009.013177

Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b

Katia Todoerti, Valentina Barbui, Olga Pedrini, Marta Lionetti, Gianluca Fossati, Paolo Mascagni, Alessandro Rambaldi, Antonino Neri, Martino Introna, Luigia Lombardi, Josée Golay

https://doi.org/10.3324/haematol.2009.012088

Hematocrit and risk of venous thromboembolism in a general population. The Tromsø study

Sigrid K. Brækkan, Ellisiv B. Mathiesen, Inger Njølstad, Tom Wilsgaard, John-Bjarne Hansen

https://doi.org/10.3324/haematol.2009.008417

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

Dominique Farge, Myriam Labopin, Alan Tyndall, Athanasios Fassas, Gian Luigi Mancardi, Jaap Van Laar, Jian Ouyang, Tomas Kozak, John Moore, Ina Kötter, Virginie Chesnel, Alberto Marmont, Alois Gratwohl, Riccardo Saccardi

https://doi.org/10.3324/haematol.2009.013458

Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1

Matt Wenham, Samantha Grieve, Michelle Cummins, Matthew L. Jones, Sarah Booth, Rachel Kilner, Philip J. Ancliff, Gillian M. Griffiths, Andrew D. Mumford

https://doi.org/10.3324/haematol.2009.012286

Errata Corrige

Letters to the Editor

Development of an ELISA strip for the detection of α thalassemias

Luksana Makonkawkeyoon, Somphon Pharephan, Pannee Sirivatanapa, Wirote Tuntiwechapikul, Sanit Makonkawkeyoon

https://doi.org/10.3324/haematol.2009.016592

Myelodysplastic Syndromes


Myelodysplastic Syndromes

Brief Reports

Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1

Doris Steinemann, Larissa Arning, Inka Praulich, Manfred Stuhrmann, Henrik Hasle, Jan Starý, Brigitte Schlegelberger, Charlotte M. Niemeyer, Christian Flotho

https://doi.org/10.3324/haematol.2009.010355

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia

Sébastien Maury, Françoise Huguet, Thibaut Leguay, Francis Lacombe, Marc Maynadié, Sandrine Girard, Adrienne de Labarthe, Emilienne Kuhlein, Emmanuel Raffoux, Xavier Thomas, Patrice Chevallier, Agnès Buzyn, André Delannoy, Yves Chalandon, Jean-Paul Vernant, Philippe Rousselot, Elizabeth Macintyre, Norbert Ifrah, Hervé Dombret, Marie-Christine Béné

https://doi.org/10.3324/haematol.2009.010306

Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia

Georg Aue, Margaret A. Lindorfer, Paul V. Beum, Andrew W. Pawluczkowycz, Berengere Vire, Thomas Hughes, Ronald P. Taylor, Adrian Wiestner

https://doi.org/10.3324/haematol.2009.012484

Decision Making and Problem Solving

Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations

Bilal Mohty, Jean El-Cheikh, Ibrahim Yakoub-Agha, Philippe Moreau, Jean-Luc Harousseau, Mohamad Mohty

https://doi.org/10.3324/haematol.2009.012674

Retractions